Cullen Capital Management LLC bought a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 2,016,795 shares of the company’s stock, valued at approximately $259,158,000. Merck KGaA comprises approximately 2.5% of Cullen Capital Management LLC’s portfolio, making the stock its 7th biggest holding. Cullen Capital Management LLC owned about 1.56% of Merck KGaA at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Gables Capital Management Inc. bought a new stake in Merck KGaA in the second quarter worth $2,095,000. Diversify Advisory Services LLC bought a new position in Merck KGaA during the second quarter valued at $3,810,000. Danske Bank A S bought a new position in Merck KGaA during the second quarter valued at $276,535,000. Danica Pension Livsforsikringsaktieselskab purchased a new position in shares of Merck KGaA in the 2nd quarter worth $25,541,000. Finally, BOK Financial Private Wealth Inc. purchased a new position in shares of Merck KGaA in the 2nd quarter worth $523,000. 0.10% of the stock is owned by hedge funds and other institutional investors.
Merck KGaA Stock Performance
Merck KGaA stock opened at $163.45 on Tuesday. The company’s 50-day moving average price is $162.78 and its 200-day moving average price is $148.59. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The company has a market cap of $21.12 billion, a PE ratio of 24.95 and a beta of 0.96. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
